急性脑损伤有创通气成人预防性抗生素的系统评价与Meta分析
该系统评价与Meta分析纳入7项随机对照试验共835例急性脑损伤有创通气成人,评估预防性肠外抗生素对医院死亡率的影响。预防性抗生素与死亡率降低无显著关联(RR 0.91,95%CI 0.70-1.17;低确定性),但呼吸机相关性肺炎发生率降低(RR 0.56,95%CI 0.35-0.89;低确定性),机械通气时长和ICU住院时长无显著差异。
要点
- 预防性抗生素未显著降低急性脑损伤有创通气成人的医院死亡率。
- 预防性抗生素可降低呼吸机相关性肺炎发生率(RR 0.56,95%CI 0.35-0.89)。
- 机械通气时长和ICU住院时长在两组间无显著差异,证据确定性极低。
核心结论
- 现有随机对照试验证据不能确定预防性抗生素对ICU内急性脑损伤有创通气成人死亡率的影响。
研究设计与样本
- 系统评价与Meta分析,检索电子数据库及未发表试验,纳入7项随机对照试验共835例参与者。
- 采用随机效应模型合并二分类结局的风险比(RR)和连续结局的均数差(MD),并用GRADE方法评价证据确定性。
主要发现
- 预防性抗生素与呼吸机相关性肺炎关联的合并RR为0.56(95%CI 0.35-0.89;低确定性)。
- 预防性抗生素组与对照组机械通气时长MD为-2.0天(95%CI -6.1至2.1天;极低确定性)。
- 预防性抗生素组与对照组ICU住院时长MD为-2.2天(95%CI -5.4至1.1天;极低确定性)。
临床怎么用
- 当前证据不支持常规使用预防性肠外抗生素以降低急性脑损伤有创通气成人的死亡率。
- 预防性抗生素虽可降低呼吸机相关性肺炎发生率,但需结合低确定性证据及个体情况权衡利弊。
局限性
- 纳入研究数量有限(7项随机对照试验,835例参与者),证据确定性为低至极低。
- 未提供预防性抗生素对死亡率影响的确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower respiratory tract infections are common in patients receiving invasive mechanical ventilation in an ICU after an acute brain injury and may have deleterious consequences. RESEARCH QUESTION: In adults with acute brain injury receiving invasive mechanical ventilation in an ICU, is the administration of prophylactic parenteral antibiotics, compared with placebo or usual care, associated with reduced mortality? STUDY DESIGN AND METHODS: We conducted a systematic review and meta-analysis. We searched for randomized clinical trials in electronic databases, as well as unpublished trials. The primary outcome was hospital mortality, and secondary outcomes included the incidence of ventilator-associated pneumonia, ICU length of stay, and duration of mechanical ventilation. We used a random effects model to estimate the pooled risk ratio (RR) with corresponding 95% CI for binary outcomes and the mean difference (MD) with 95% CI for continuous outcomes. Certainty of evidence was evaluated using Grading of Recommendations Assessment Development and Evaluation methods. RESULTS: One thousand seven hundred twenty-eight reports of studies were screened, with 7 randomized controlled trials recruiting 835 participants included. No trials were adjudicated as having a high risk of bias. The pooled estimated RR for mortality associated with the use of prophylactic antibiotics was 0.91 (95% CI, 0.70-1.17; P = .39; low certainty). The pooled estimated RR for ventilator-associated pneumonia was 0.56 (95% CI, 0.35-0.89; low certainty). The pooled estimated duration of mechanical ventilation for those allocated to prophylactic antibiotics compared with control participants (MD, -2.0 days; 95% CI, -6.1 to 2.1 days; very low certainty) and duration of ICU admission (MD, -2.2 days; 95% CI, -5.4 to 1.1 days; very low certainty) were similar. INTERPRETATION: Current evidence from randomized clinical trials does not provide definitive evidence regarding the effect of prophylactic antibiotics on mortality in patients receiving invasive mechanical ventilation in the ICU. CLINICAL TRIAL REGISTRY: International Prospective Register of Systematic Reviews; No.: CRD42023424732; URL: https://www.crd.york.ac.uk/prospero/.
引用
- Hadley-Brown K, Hailstone L, Devane R, et al. Prophylactic Antibiotics in Adults With Acute Brain Injury Who Are Invasively Ventilated in the ICU: A Systematic Review and Meta-Analysis. Chest. 2024. PMID: 39490972. doi:10.1016/j.chest.2024.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。